← Back to screener

INSMED Inc INSM

Rank #2520 · Nasdaq · $24.4B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
8.8
P/E
-32.6
P/B
277.45
ROE
-852.3%
Op. Margin
-232.5%
Debt Ratio
1978%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -32.6x, P/B 277.45x. Ranks in the top 84% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -852.3%. Ranks in the top 96% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 1978%. Ranks in the top 97% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆
Excellent

Revenue growth of 24.4% year over year. Ranks in the top 15% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.0B$-0.0B$0.1B$-0.0B-83.6-121
2012$0.0B$-0.0B$-0.0B$0.1B-116.94
2013$0.0B$-0.1B$-0.1B$0.2B-1397.317
2014$0.0B$-0.0B$-0.0B$0.1B-369.025
2015$0.0B$-0.1B$-0.1B$0.1B-478.437
2016–$-0.1B$-0.1B$0.1B–31
2017$0.0B$-0.1B$-0.1B$0.2B–45
2018$0.0B$-0.2B$-0.2B$0.3B–32
2019$0.0B$-0.2B$-0.2B$0.2B–257
2020$0.0B$-0.3B$-0.3B$0.4B-3124.9133
2021$0.1B$-0.2B$-0.3B$0.2B-172.4250
2022$0.2B$-0.3B$-0.3B$0.3B-161.3318
2023$0.2B$-0.4B$-0.4B$0.3B-199.0569
2024$0.2B$-0.5B$-0.5B$0.4B-186.4405
2025$0.3B$-0.7B$-0.7B$0.1B-232.51978

← See the full screener